Salivary Gland Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-05-23
Clinical Trial Update: Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies [Phase 2]
A Phase 2 trial evaluating postoperative radiotherapy combined with panitumumab for high-risk salivary gland cancer has been withdrawn.